151 related articles for article (PubMed ID: 21431403)
1. Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablation.
Liapi E; Geschwind JF
Ann Surg Oncol; 2011 Jun; 18(6):1527-8. PubMed ID: 21431403
[No Abstract] [Full Text] [Related]
2. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
[TBL] [Abstract][Full Text] [Related]
3. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
Morimoto M; Numata K; Kondou M; Nozaki A; Morita S; Tanaka K
Cancer; 2010 Dec; 116(23):5452-60. PubMed ID: 20672352
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
Peng ZW; Chen MS
Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
Yi PS; Huang M; Zhang M; Xu L; Xu MQ
Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
Tashiro H; Aikata H; Waki K; Amano H; Oshita A; Kobayashi T; Tanimoto Y; Kuroda S; Tazawa H; Chayama K; Asahara T; Ohdan H
J Surg Oncol; 2011 Jul; 104(1):3-9. PubMed ID: 21656523
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
Qi X; Zhao Y; Li H; Guo X; Han G
Oncotarget; 2016 Jun; 7(23):34703-51. PubMed ID: 27167195
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.
Chen QW; Ying HF; Gao S; Shen YH; Meng ZQ; Chen H; Chen Z; Teng WJ
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):309-314. PubMed ID: 26428660
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
Takaki H; Yamakado K; Nakatsuka A; Fuke H; Murata K; Shiraki K; Takeda K
J Vasc Interv Radiol; 2007 Jul; 18(7):856-61. PubMed ID: 17609444
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology.
Yamakado K; Nakatsuka A; Ohmori S; Shiraki K; Nakano T; Ikoma J; Adachi Y; Takeda K
J Vasc Interv Radiol; 2002 Dec; 13(12):1225-32. PubMed ID: 12471186
[TBL] [Abstract][Full Text] [Related]
12. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation combined with chemoembolization for early-stage hepatocellular carcinoma.
Cho YK
Radiology; 2008 Nov; 249(2):718-9; author reply 719. PubMed ID: 18936322
[No Abstract] [Full Text] [Related]
16. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
17. Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis.
Chu HH; Kim JH; Yoon HK; Ko HK; Gwon DI; Kim PN; Sung KB; Ko GY; Kim SY; Park SH
J Vasc Interv Radiol; 2019 Oct; 30(10):1533-1543. PubMed ID: 31471190
[TBL] [Abstract][Full Text] [Related]
18. Liver tumors and loco-regional therapy.
Vogel W
Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251
[No Abstract] [Full Text] [Related]
19. [RCT of chemoembolization plus rediofrequency ablation versus liver resection for hepatocellular carcinoma].
Strobel O; Büchler MW
Chirurg; 2016 Jun; 87(6):533. PubMed ID: 27251481
[No Abstract] [Full Text] [Related]
20. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
